Clinical Trial: Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07290244) titled 'Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)' on Nov. 19.

Brief Summary: The goal of this clinical trial is to evaluate the safety and tolerability of a single dose of ER-100 in adults with optic nerve conditions, specifically Open Angle Glaucoma (OAG) and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). The main questions it aims to answer are:

* Is ER-100 safe when given as a single dose to people with OAG or NAION

* What side effects may occur, if any, after taking ER-100?

Participants will:

* Receive a single dose of ER-100

* Under...